1. Home
  2. PDEX vs IFRX Comparison

PDEX vs IFRX Comparison

Compare PDEX & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDEX
  • IFRX
  • Stock Information
  • Founded
  • PDEX 1978
  • IFRX 2007
  • Country
  • PDEX United States
  • IFRX Germany
  • Employees
  • PDEX N/A
  • IFRX N/A
  • Industry
  • PDEX Medical/Dental Instruments
  • IFRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDEX Health Care
  • IFRX Health Care
  • Exchange
  • PDEX Nasdaq
  • IFRX Nasdaq
  • Market Cap
  • PDEX 117.9M
  • IFRX 117.8M
  • IPO Year
  • PDEX N/A
  • IFRX 2017
  • Fundamental
  • Price
  • PDEX $51.40
  • IFRX $1.05
  • Analyst Decision
  • PDEX Strong Buy
  • IFRX Strong Buy
  • Analyst Count
  • PDEX 1
  • IFRX 2
  • Target Price
  • PDEX $52.00
  • IFRX $9.00
  • AVG Volume (30 Days)
  • PDEX 41.3K
  • IFRX 356.5K
  • Earning Date
  • PDEX 05-01-2025
  • IFRX 03-20-2025
  • Dividend Yield
  • PDEX N/A
  • IFRX N/A
  • EPS Growth
  • PDEX 128.87
  • IFRX N/A
  • EPS
  • PDEX 1.93
  • IFRX N/A
  • Revenue
  • PDEX $61,004,000.00
  • IFRX $171,642.00
  • Revenue This Year
  • PDEX $28.63
  • IFRX $381.73
  • Revenue Next Year
  • PDEX $3.09
  • IFRX $2,277.23
  • P/E Ratio
  • PDEX $26.58
  • IFRX N/A
  • Revenue Growth
  • PDEX 26.45
  • IFRX 162.79
  • 52 Week Low
  • PDEX $16.84
  • IFRX $1.01
  • 52 Week High
  • PDEX $59.60
  • IFRX $2.82
  • Technical
  • Relative Strength Index (RSI)
  • PDEX 67.45
  • IFRX 31.57
  • Support Level
  • PDEX $47.00
  • IFRX $1.16
  • Resistance Level
  • PDEX $52.00
  • IFRX $1.30
  • Average True Range (ATR)
  • PDEX 2.56
  • IFRX 0.12
  • MACD
  • PDEX 0.05
  • IFRX 0.02
  • Stochastic Oscillator
  • PDEX 91.84
  • IFRX 9.76

About PDEX Pro-Dex Inc.

Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: